Citations 267
Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms
Shultz, Carl , Al‐Kali, Aref , Chhetri, Rakchha , Arsana, Arini, Stish, Bradley J. , Tefferi, Ayalew , Patnaik, Mrinal M. , Gangat, Naseema , Baranwal, Anmol , Tran, Elizabeth Ngoc Hoa , Alkhateeb, Hassan B. , Hiwase, Devendra , Shah, Meera
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6309-6311
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy
Barreto, Jason N. , Frazee, Erin N. , Powell, Marissa , Bansal, Radhika , Hathcock, Matthew , Nedved, Adrienne, Ansell, Stephen M. , Johnston, Patrick B. , Sandahl, Tyler B. , Khurana, Arushi , Kapoor, Prashant , Kumar, Shaji , Kourelis, Taxiarchis , Warsame, Rahma , Hayman, Suzanne R. , Lin, Yi , Mara, Kristin C. , Rule, Andrew D. , Herrmann, Sandra M. , Bennani, N. Nora , Paludo, Jonas , Durani, Urshila , Wang, Yucai , Alkhateeb, Hassan B. , Shah, Meera , Gertz, Morie A. , Dingli, David , Leung, Nelson
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10942-10944
High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group
Abeykoon, Jithma P., Medina, Aldo Acosta, Zanwar, Saurabh , Ruan, Gordon, Jiang, Liuyan , Gruber, Lucinda , Davidge‐Pitts, Caroline , Wu, Xiaosheng , McNinch, Colton M, Dasari, Surendra , Goyal, Gaurav , Abeykoon, Jithma P. , Rech, Karen L. , Ravindran, Aishwarya , Koster, Matthew J. , Tobin, W. Oliver , Vassallo, Robert , Ryu, Jay H. , Bennani, N. Nora , Shah, Meera , Young, Jason R. , McNinch, Colton M, Go, Ronald S.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 32-33
Prevalence and Impact of Clonal Hematopoiesis in Therapy Related Myeloid Neoplasms Occurring in the Context of Low-Grade Follicular Lymphoma Treated with Radioisotope Therapy
Lasho, Terra, Khurana, Arushi , Finke, Christy M. , Mangaonkar, Abhishek A. , Ansell, Stephen M. , Al‐Kali, Aref , Gangat, Naseema , Abeykoon, Jithma P. , Patnaik, Mrinal M. , Xie, Zhuoer , Ferrer, Alejandro , Fernandez, Jenna , Shah, Meera , Witzig, Thomas E.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11403-11405
Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms
Ladon, Dariusz, Chhetri, Rakchha , Sharplin, Kirsty, Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Kebede, Ashanka Begna, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Kok, Chung Hoow , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Alkhateeb, Hassan B. , Singhal, Deepak , Yeung, David , Ross, David M , Hogan, William J. , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Shah, Meera , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6962-6963
Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome
Chhetri, Rakchha , Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Begna, Kebede, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Singhal, Deepak , Hogan, William J. , Kutyna, Monika , Alkhateeb, Hassan B. , Baranwal, Anmol , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965